This new generic medicine is designed to be a simple, once-daily treatment for children as young as three months old who ...

Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...

Drug firm Lupin on Friday said it has received approval from the US health regulator to market a generic HIV medication in ...

Lupin receives US FDA approval for sacubitril and valsartan tablets: Our Bureau, Mumbai Friday, January 24, 2025, 15:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) announc ...

Lupin receives US FDA marketing nod for generic Triumeq PD tablets for oral suspension to trteat HIV-1 infection: Our Bureau, Mumbai Friday, January 24, 2025, 14:15 Hrs [IST] Glob ...

AM (IST) on Wednesday, 0.62 per cent from previous close. The stock quoted a 52-week low price of Rs 1411.15 and a high of Rs ...

Lupin Share Price: Shares of pharmaceutical major Lupin Limited hit their 52-week high on the last trading day of calendar year 2024. The BSE 100 listed stock rallied around 2.5 per cent during ...

Today’s stock recommendations feature a mix of picks from the pharmaceutical, insurance, and chemicals sectors.

Mumbai: Global pharma major Lupin Limited has announced the launch of Minzoya (Levonorgestrel and Ethinyl Estradiol Tablets, ...

Global pharma major Lupin Limited on Thursday announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug ...

Lupin has received USFDA approval to market a generic HIV medication in the US market, under the PEPFAR program. The drug ...